Canada markets closed

Chugai Pharmaceutical Co., Ltd. (CUP.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
28.83+0.09 (+0.31%)
At close: 03:29PM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 48.57B
Enterprise Value 44.01B
Trailing P/E 24.35
Forward P/E 22.68
PEG Ratio (5 yr expected) 6.86
Price/Sales (ttm)7.67
Price/Book (mrq)4.84
Enterprise Value/Revenue 0.03
Enterprise Value/EBITDA 0.07

Trading Information

Stock Price History

Beta (5Y Monthly) 0.51
52-Week Change 320.12%
S&P500 52-Week Change 326.27%
52 Week High 339.80
52 Week Low 323.80
50-Day Moving Average 333.35
200-Day Moving Average 331.16

Share Statistics

Avg Vol (3 month) 383
Avg Vol (10 day) 35
Shares Outstanding 51.65B
Implied Shares Outstanding 61.68B
Float 8639.35M
% Held by Insiders 159.91%
% Held by Institutions 118.71%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.52
Forward Annual Dividend Yield 41.79%
Trailing Annual Dividend Rate 380.00
Trailing Annual Dividend Yield 3278.36%
5 Year Average Dividend Yield 41.77
Payout Ratio 440.33%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 27, 2024
Last Split Factor 23:1
Last Split Date 3Jun 29, 2020

Financial Highlights

Currency in JPY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 31.50%
Operating Margin (ttm)42.15%

Management Effectiveness

Return on Assets (ttm)15.01%
Return on Equity (ttm)21.20%

Income Statement

Revenue (ttm)1.04T
Revenue Per Share (ttm)629.73
Quarterly Revenue Growth (yoy)-24.10%
Gross Profit (ttm)N/A
EBITDA 467.56B
Net Income Avi to Common (ttm)326.37B
Diluted EPS (ttm)1.18
Quarterly Earnings Growth (yoy)1.20%

Balance Sheet

Total Cash (mrq)764.57B
Total Cash Per Share (mrq)464.67
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)5.53
Book Value Per Share (mrq)997.97

Cash Flow Statement

Operating Cash Flow (ttm)383.09B
Levered Free Cash Flow (ttm)287.75B